Cigna Corp (CI)
$353.99
7.52 (2.17%)
CI Stock Quote Delayed 30 Minutes
Dow Delights on Election Day — Tuesday’s IP Market Recap
Hewlett-Packard and Boeing helped lead the Dow to strong gains Tuesday, while the other major indices mostly followed suit.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
120.39B
PE Ratio
27.83
EPS
12.72
Volume (Avg. Vol.)
1.43M
Day's Range
$346.15 - $354.49
52-Week Range
$253.95 - $365.71
Dividend & Yield
$4.92 (1.39%)
CI Stock Predictions, Articles, and Cigna Corp News
The Nation’s Finest: 10 Best Real America Index Performers
Two-thirds of the members of InvestorPlace's handpicked Real America Index have seen gains this year. Have a look at our 10 best performers.
Top 6 Stocks to Buy for September
These six picks should provide for a higher-than-average degree of stability and return despite the international risks. See this month's buy list.
7 Health Care Provider Stocks to Buy Now
This week, seven Health Care Provider stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
3 Reasons CVS Caremark Looks Healthy
CVS reported strong earnings on Monday -- and Wall Street punished it in any case. The market’s gut reaction missed a lot of positives.
CVS Caremark Tops Q2 Profit, Misses on Revenue
CVS Caremark posted increased second-quarter earnings that topped Wall Street forecasts, but missed on revenue, and raised its earnings outlook for the year.
Comparison Shopping 3 Supermarket Stocks
Kroger, SuperValu or Whole Foods: Which belongs in your cart? One is fresh, one is stale and one is worth buying when it goes on sale.
All Earnings, All the Time — Thursday’s IP Market Recap
Tech stocks ruled the day as strong earnings in the sector and across the board helped lift markets to gains Thursday.
10 Dividend Stocks the Market Left Behind
While investors have been flocking toward dividend stocks in a mad dash to safety, these 10 high-yielding picks have been mostly ignored.
Should I Buy Procter & Gamble? 3 Pros, 3 Cons
The consumer-products giant face plenty of challenges ahead, but William Ackman's involvement should put a floor under the stock.
Court Speaks, Markets Listen — Thursday’s IP Market Recap
The Supreme Court ruling in favor of Obama's Affordable Care Act hit markets initially, but the indices managed to cut most losses by the end of the day.
7 Companies That Might Be the ‘Next Apple’
Which company will become the next great Apple-esque growth story? Seven InvestorPlace writers sound off on the stocks they think could take off.
Why I Went Long Coinstar
The recently announced deal with Starbucks is proof positive that the kiosk vending concept will not only work, but will be a blockbuster for Coinstar.
Walgreen No Longer Fills the Prescription
Walgreen's earnings and revenues are under pressure after they gave up a relationship with Express Script's in 2011. Look to sell Walgreen.
Which Is Healthier, CVS or Walgreen?
WAG lags after the loss of Express Scripts, but acquiring Rite Aid could restore its health.
Health Insurers Weathering Sickly Q1 Results
A large swath of managed care companies had lousy Q1 earnings, but few have fallen to bargain prices. Are there any values to be found in the sector?
Green Mountain Coffee Grounded — Wednesday’s IP Market Recap
After a lackluster day for the markets, Green Mountain set off fireworks with disappointing K-Cup sales and a lowered forecast that sent GMCR shares plunging.
Citigroup: To Pay or Not to Pay
It's in a bind after shareholders reject Vikram Pandit's $15 million pay package. But is that really an "obscene" amount?
Analysts Run the Apple Asylum — Tuesday’s IP Market Recap
Price targets keep climbing to the moon: $715, $910 -- even $1,001.
5 Big-Time CEOs and Their Paychecks
Recently released compensation figures show the CEO of one of the market’s best companies took a pay cut last year. Who got a raise?
